US Patent 11396550 Methods of treating comprising administering anti-OX40L antibodies
Patent 11396550 was granted and assigned to Kymab on July, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 11 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 5 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 13 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 22 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
113965500
Date of Patent
July 26, 2022
0Patent Application Number
156616580
Date Filed
July 27, 2017
0Patent Citations
Patent Primary Examiner
Edits on 23 Mar, 2023
Golden AI
Infobox
Edits on 28 Sep, 2022
Golden AI
Infobox
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
113965500
Date of Patent
July 26, 2022
0Patent Application Number
156616580
Date Filed
July 27, 2017
0Patent Citations
Patent Primary Examiner
Edits on 27 Jul, 2022
Golden AI
Edits made to:
Infobox (+11 properties)
Article (+91 characters)
US Patent 11396550 Methods of treating comprising administering anti-OX40L antibodies
Article
The present invention relates to anti-human OX40L antibodies, new medical uses and methods.
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11396550
Date of patent
July 26, 2022
Patent application number
15661658
Date Filed
July 27, 2017
Patent citations
Patent primary examiner
Find more entities like US Patent 11396550 Methods of treating comprising administering anti-OX40L antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
